Design, recruitment, and baseline characteristics of the LENS trial
<p><strong>Background:</strong> Findings from cardiovascular outcome trials suggest that treatment with fenofibrate may reduce the progression of diabetic retinopathy. However, no dedicated large-scale randomised trials have yet investigated this hypothesis.</p> <...
Yazar: | |
---|---|
Diğer Yazarlar: | |
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wiley
2024
|